Bortezomib just for induction or also for maintenance in myeloma patients with renal impairment? by Jesús F. San Miguel

Get full text

Can multiple myeloma become a curable disease? by Jesús F. San-Miguel, María-Victoria Mateos

Get full text

Reply to “Response to “CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype”. Haematologica... by Teresa Paíno, Bruno Paiva, Jesús F. San Miguel

Get full text

Antonio López Borrasca (1926–2008) by Jesús F. San Miguel, Vicente Vicente Garcia, Javier Batlle, Eduardo Rocha

Get full text

Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity by Juan Carlos Montero, Ricardo López-Pérez, Jesús F. San Miguel, Atanasio Pandiella

Get full text

Is immunotherapy here to stay in multiple myeloma? by Paula Rodríguez-Otero, Bruno Paiva, Monika Engelhardt, Felipe Prósper, Jesús F. San Miguel

Get full text

Use of bortezomib in the management of chronic graft-versus-host disease among multiple myeloma patients relapsing after allogeneic transplantation by Juan Mateos-Mazon, José-Antonio Pérez-Simón, Olga Lopez, Emiliano Hernández, Jaime Etxebarria, Jésus F. San Miguel

Get full text

Measurable residual disease in multiple myeloma: ready for clinical practice? by Leire Burgos, Noemi Puig, Maria-Teresa Cedena, María-Victoria Mateos, Juan José Lahuerta, Bruno Paiva, Jesús F. San-Miguel

Get full text

Using quantification of the PML-RARα transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia by Carlos Santamaría, Maria Carmen Chillón, Carina Fernández, Patricia Martín-Jiménez, Ana Balanzategui, Ramón García Sanz, Jesús F. San Miguel, Marcos-Gonzalez González

Get full text

Deficient spindle assembly checkpoint in multiple myeloma. by Elena Díaz-Rodríguez, Stela Álvarez-Fernández, Xi Chen, Bruno Paiva, Ricardo López-Pérez, Juan Luis García-Hernández, Jesús F San Miguel, Atanasio Pandiella

Get full text

Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide? by Sergio Matarraz, Bruno Paiva, María Diez-Campelo, Lucia-López Corral, Estefanía Pérez, Maria-Victoria Mateos, Pilar Giraldo, Miguel T. Hernández, Jesús F. San Miguel, Alberto Orfao

Get full text

Immunophenotypic Characterization of Human Bone Marrow Mast Cells. A Flow Cytometric Study of Normal and Pathological Bone Marrow Samples by Luis Escribano, Alberto Orfao, Jesús Villarrubia, Beatriz Díaz-Agustín, Carlos Cerveró, Agustín Rios, José L. Velasco, Juana Ciudad, José L. Navarro, Jesús F. San Miguel

Get full text

CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype by Teresa Paíno, Enrique M. Ocio, Bruno Paiva, Laura San-Segundo, Mercedes Garayoa, Norma C. Gutiérrez, M. Eugenia Sarasquete, Atanasio Pandiella, Alberto Orfao, Jesús F. San Miguel

Get full text

Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients by Bruno Paiva, Maria-Belén Vidriales, Jose J. Pérez, Gema Mateo, Maria Angeles Montalbán, Maria Victoria Mateos, Joan Bladé, Juan José Lahuerta, Alberto Orfao, Jesús F. San Miguel

Get full text

The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype by Enrique Colado, Stela Álvarez-Fernández, Patricia Maiso, Jesús Martín-Sánchez, Maria Belén Vidriales, Mercedes Garayoa, Enrique M. Ocio, Juan Carlos Montero, Atanasio Pandiella, Jesús F. San Miguel

Get full text

CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features by Martin Schmidt-Hieber, Martin Pérez-Andrés, Bruno Paiva, Juan Flores-Montero, Jose J. Perez, Norma C. Gutierrez, Maria-Belen Vidriales, Sergio Matarraz, Jesus F. San Miguel, Alberto Orfao

Get full text

Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomat... by María E. Sarasquete, Norma C. Gutiérrez, Irena Misiewicz-Krzeminska, Bruno Paiva, María C. Chillón, Miguel Alcoceba, Ramón García-Sanz, Jesús M. Hernández, Marcos González, Jesús F. San-Miguel

Get full text

Bone marrow mesenchymal stem cells for improving hematopoietic function: an in vitro and in vivo model. Part 2: Effect on bone marrow microenvironment. by Soraya Carrancio, Belen Blanco, Carlos Romo, Sandra Muntion, Natalia Lopez-Holgado, Juan F Blanco, Jesus G Briñon, Jesus F San Miguel, Fermin M Sanchez-Guijo, M Consuelo del Cañizo

Get full text

The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes by Soraya Tabera, José A. Pérez-Simón, María Díez-Campelo, Luis I. Sánchez-Abarca, Belén Blanco, Antonio López, Ana Benito, Enrique Ocio, Fermín M. Sánchez-Guijo, Consuelo Cañizo, Jesús F. San Miguel

Get full text

Evidence of long-term disease control with panobinostat maintenance in patients with relapsed multiple myeloma by Enrique M. Ocio, Julio Dávila, Juan-Carlos Caballero, Sara Alonso, Verónica González de la Calle, Ramón García-Sanz, Lucien Gazi, Socrates Opio, Mónica Jiménez, Jesús F. San-Miguel, María-Victoria Mateos

Get full text